Skip to Main Content

Science, technology, and health care in focus

Register now

Medicine’s new dawn

We are about to have more data about human biology than ever before. That is changing how medicines are invented, how they are prescribed, and how patients and physicians interact with unprecedented speed. Medicine has gone from faxes to electronic health records to large language models, from mouse models to organs on a chip to gene editing.

But the biggest — and toughest — change will come when artificial intelligence and other technologies transform the budget-straining process of turning big ideas into actual drugs, upending the economics of one of the world’s most challenging businesses. Here, STAT will ask the perennial, trenchant questions among those in the field: Are we there yet? And how much longer? This extends to an array of transformative new technologies from biotech, health tech, and the world of machine learning. Join us as DNA goes digital.

Reed Jobs, founder of the cancer-focused venture firm Yosemite, speaking with STAT’s Allison DeAngelis during Breakthrough West 2025.

STAT’s Angus Chen with Clifford Hudis (ASCO), Karen Knudsen (Parker Institute for Cancer Immunotherapy), and Danielle Bitterman (Mass General Brigham) at Breakthrough West 2025.

Secure your spot today

Are you a member of the press? Request a press pass to attend Breakthrough West in person or online.

Virtual Access

$150

Access to all sessions live and on demand via our virtual venue

General Admission

$850

All benefits of virtual access plus exclusive networking opportunities

Agency & Sales

$950

In-person access for agency, sales, and PR professionals Limited seats available

Reduced Pricing

Custom

Special rates available for government, academia, non-profit, startups, patients & patient advocates, students, and more — contact [email protected] for details

Event Scholarship Program

We are committed to making STAT events accessible. For financial support to attend Breakthrough West, apply to our event scholarship todayapplications close Sunday, April 5 at midnight ET.

Please note: All registrations are reviewed and approved by STAT’s editorial team to ensure event alignment and manage capacity. Once your order is processed, you’ll receive a confirmation within two business days. STAT reserves the right to cancel and refund registrations at its discretion. See STAT event terms & conditions for more information.

 
Joe Betts-LaCroix

Joe Betts-LaCroix

CEO, Retro Biosciences

Anne Wojcicki

Anne Wojcicki

Founder and CEO, 23andMe Research Institute

Zachary Ziegler

Zachary Ziegler

Co-founder and CTO, OpenEvidence

Neil Kumar Ph.D.

Neil Kumar Ph.D.

Chief Executive Officer and Founder, BridgeBio Pharma, Inc.

Whitney Thompson, M.D., M.Phil

Whitney Thompson, M.D., M.Phil

Physician, Mayo Clinic

Marc Tessier-Lavigne, Ph.D.

Marc Tessier-Lavigne, Ph.D.

Co-Founder, Chairman and CEO, Xaira Therapeutics

Ted W. Love, M.D.

Ted W. Love, M.D.

Immediate Past Chair, BIO; Former CEO, GBT

Mark Sendak, M.D.

Mark Sendak, M.D.

Co-Founder and CEO, Vega Health

 

A special thanks to our sponsors

Presenting Sponsor

Premium Sponsors

Supporting Sponsor

Contact

Stay in the loop

Join our email list

Sign up today for summit news and updates

Questions?

Contact us at [email protected] with any questions or to register as press

Terms & Conditions